Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Empagliflozin Tablets

Approval Number

国药准字H20253201

Company山东新华制药股份有限公司

Registration Date

January 14, 2025

Drug Information

Generic Name

恩格列净片

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

January 14, 2025

Company Information

Applicant Company

Company Name山东新华制药股份有限公司

Company Address

淄博市高新技术产业开发区化工区

Manufacturing Company

Company Name山东新华制药股份有限公司

Company Address

山东省淄博市高新区鲁泰大道1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

恩格列净片 - NMPA 批准文号 | MedPath